Enbrel (etanercept)
Enbrel (etanercept) is a pharmaceutical drug with 14 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
92.3%
12 of 13 finished
7.7%
1 ended early
1
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis
A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
Clinical Trials (14)
A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis
A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Extension Study Evaluating Etanercept in Ankylosing Spondylitis
Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan
Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children
Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis
An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14